You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LAG525, NIR178, INC280, MCS110, ACZ885

Showing 1 - 25 of 81
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple-negative Breast Cancer Trial in Worldwide (LAG525, Spartalizumab, Carboplatin)

Completed
Has Results
  • Triple-negative Breast Cancer
  • Chandler, Arizona
  • +32 more
Jan 27, 2023

NSCLC Trial in Worldwide (INC280 (capmatinib))

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • INC280 (capmatinib)
  • Long Beach, California
  • +95 more
Dec 29, 2022

NSCLC (NSCLC), Triple Negative Breast Cancer (TNBC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in Worldwide (NZV930, PDR001,

Terminated
  • Non-small Cell Lung Cancer (NSCLC)
  • +6 more
  • NZV930
  • +2 more
  • Tampa, Florida
  • +9 more
Nov 2, 2022

Advanced Solid Tumors Trial in Worldwide (LAG525, PDR001)

Completed
Has Results
  • Advanced Solid Tumors
  • New York, New York
  • +23 more
Jan 17, 2022

Small Cell Lung Cancer, Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in United States (PDR001, LAG525)

Completed
Has Results
  • Small Cell Lung Cancer
  • +7 more
  • PDR001
  • LAG525
  • San Francisco, California
  • +19 more
May 4, 2022

Melanoma Trial in Boston (MCS110, Dabrafenib, Trametinib)

Active, not recruiting
  • Melanoma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 14, 2022

Advanced Hepatocellular Carcinoma With c-MET Dysregulation Trial in Worldwide (INC280)

Active, not recruiting
  • Advanced Hepatocellular Carcinoma With c-MET Dysregulation
  • Nanjing, Jiangsu, China
  • +7 more
Jan 12, 2023

EGFR-mutant NSCLC Trial in Worldwide (EGF816, trametinib, ribociclib)

Active, not recruiting
  • EGFR-mutant Non-small Cell Lung Cancer
  • Toronto, Ontario, Canada
  • +10 more
Dec 5, 2022

Solid Tumors Trial in Worldwide (KAZ954, PDR001, NIR178)

Recruiting
  • Solid Tumors
  • Los Angeles, California
  • +12 more
Dec 23, 2022

Triple Negative Breast Cancer, Pancreatic Carcinoma, Melanoma Trial in Worldwide (MCS110, PDR001)

Completed
Has Results
  • Triple Negative Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +19 more
Jul 12, 2021

Non Small Cell Lung Cancer Trial in Worldwide (EGF816, INC280, Nivolumab)

Terminated
Has Results
  • Non Small Cell Lung Cancer
  • Houston, Texas
  • +12 more
Jan 31, 2022

Carcinoma, Renal Cell Trial in Worldwide (DFF332, RAD001, PDR001)

Recruiting
  • Carcinoma, Renal Cell
  • Duarte, California
  • +10 more
Jun 13, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Capmatinib, Nazartinib)

Terminated
  • Non Small Cell Lung Cancer
  • Boston, Massachusetts
  • +18 more
Jul 20, 2022

Advanced Hepatocellular Carcinoma Trial in Worldwide (PDR001, INC280)

Completed
  • Advanced Hepatocellular Carcinoma
  • Toronto, Ontario, Canada
  • +16 more
Jul 29, 2021

Sickle Cell Anemia Trial in Worldwide (ACZ885, Placebo)

Completed
Has Results
  • Sickle Cell Anemia
  • Atlanta, Georgia
  • +14 more
Oct 7, 2021

Pulmonary Sarcoidosis Trial in Germany, Netherlands, United States (ACZ885, Placebo)

Completed
Has Results
  • Pulmonary Sarcoidosis
  • Birmingham, Alabama
  • +7 more
Sep 30, 2021

Pigmented Villonodular Synovitis, PVNS, Giant Cell Tumor of the Tendon Sheath Trial in Switzerland, United States (MCS110,

Completed
Has Results
  • Pigmented Villonodular Synovitis
  • +5 more
  • San Diego, California
  • +7 more
Dec 9, 2020

Metastatic Pancreatic Ductal Adenocarcinoma Trial in Boston, New York (Canakinumab injection; spartalizumab, nab-paclitaxel,

Active, not recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Canakinumab injection; spartalizumab, nab-paclitaxel, gemcitabine
  • Boston, Massachusetts
  • +1 more
Apr 5, 2022

Prostate Cancer, Bone Metastases Trial in Las Vegas, San Antonio (MCS110)

Terminated
  • Prostate Cancer
  • Bone Metastases
  • Las Vegas, Nevada
  • +1 more
Dec 11, 2020

Abdominal Aortic Aneurysm (AAA) Trial in Worldwide (ACZ885, Placebo)

Terminated
Has Results
  • Abdominal Aortic Aneurysm (AAA)
  • Charlottesville, Virginia
  • +8 more
Dec 9, 2020

Rheumatoid Arthritis Trial in Worldwide (Canakinumab)

Completed
Has Results
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +50 more
Jun 17, 2021

Advanced Solid Tumor Trial in Kashiwa, Fukuoka (INC280)

Completed
  • Advanced Solid Tumor
  • Kashiwa, Chiba, Japan
  • +1 more
Dec 16, 2020

NSCLC (NSCLC) Trial in China (Capmatinib)

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • Xiamen, Fujian, China
  • +18 more
Jan 27, 2023

Kidney Cancer Trial run by the NCI (INC280)

Completed
  • Kidney Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 18, 2021

NSCLC Trial in Worldwide (INC280, Gefitinib)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Woolloongabba, Queensland, Australia
  • +30 more
Mar 12, 2021